Summary

The company's mission is to empower patients worldwide with access to affordable generic medicines for rare, high-risk, and complex cancers. This initiative includes a curated list of specific diagnoses such as rheumatoid arthritis, acute myeloid leukemia, advanced kidney cancer, alopecia areata, and rare cell lineages like ALK and BCR/ABL. Additionally, the mission covers critical conditions including anti-viral therapies, bladder cancer, and breast cancers, alongside specialized oncology services. A significant portion of the mission focuses on pediatric leukemia, chronic lymphocytic leukemia, and myeloid leukemia, as well as cancers specifically affecting organs like the pancreas, liver, and lungs. The program also targets severe conditions such as chronic hepatitis B and chronic hepatitis C, alongside more aggressive cancers like prostate cancer and renal cell carcinoma. Furthermore, the mission emphasizes supportive care through drugs for alopecia areata, metastatic disease management, and the treatment of blood cell cancers. While the scope includes many diverse diagnoses ranging from simple blood disorders to complex systemic conditions, the core objective remains ensuring that medical needs are met at reasonable costs for these severe and rare illnesses.

Title

Emergency Drug - Home of Generic Medicines

Description

Emergency Drug offers newly approved generic medicines at reasonable prices. Such as Osimertinib, Palbonix, Tofacitinib, Olaparib, Ibrutinib.

Keywords

cancer, tablets, kidney, breast, leukemia, limited, blood, cell, medicine, hepatitis, pharmaceuticals, products, primary, capsules, negative, cancers, stage

NS Lookup

A 77.37.50.14, A 147.79.119.167

Dates

Created 2026-03-09

Updated 2026-04-14

Summarized 2026-04-16